Abogen Biosciences
A discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics.
Launch date
Employees
Market cap
-
Enterprise valuation
€2.5—3.8b (Dealroom.co estimates Aug 2021.)
Suzhou Shi Jiangsu (HQ)
Authorizing premium user...